338 related articles for article (PubMed ID: 30146745)
1. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
Miyazaki C; Sruamsiri R; Mahlich J; Jung W
J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
[No Abstract] [Full Text] [Related]
3. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
Doria A; Iaccarino L; La Montagna G; Mathieu A; Piga M; Galeazzi M; Iuliano A; Maurel FB; Garofano AM; Perna AG; Porcasi RE
Clin Exp Rheumatol; 2015; 33(3):375-84. PubMed ID: 26005879
[TBL] [Abstract][Full Text] [Related]
5. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
[TBL] [Abstract][Full Text] [Related]
6. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
7. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
Clarke AE; Urowitz MB; Monga N; Hanly JG
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
[TBL] [Abstract][Full Text] [Related]
8. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
Hammond ER; Desta B; Near AM; Wang X; Jiang M
Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34556546
[TBL] [Abstract][Full Text] [Related]
9. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
10. Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004-2015.
Jiang M; Near AM; Desta B; Wang X; Hammond ER
Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34521733
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
12. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
Park SY; Joo YB; Shim J; Sung YK; Bae SC
Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
Lokhandwala T; Coutinho AD; Bell CF
Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
15. The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States.
Bell CF; Huang SP; Cyhaniuk A; Averell CM
Lupus; 2023 Feb; 32(2):301-309. PubMed ID: 36542670
[TBL] [Abstract][Full Text] [Related]
16. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.
He X; Lloyd E; Cooper S; Li L; Chauhan D; Juliao P; Quasny H; Bao C
Value Health Reg Issues; 2023 Sep; 37():88-96. PubMed ID: 37379801
[TBL] [Abstract][Full Text] [Related]
18. Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
Murimi-Worstell IB; Lin DH; Kan H; Tierce J; Wang X; Nab H; Desta B; Alexander GC; Hammond ER
J Rheumatol; 2021 Mar; 48(3):385-393. PubMed ID: 32611669
[TBL] [Abstract][Full Text] [Related]
19. Annual direct medical cost of active systemic lupus erythematosus in five European countries.
Doria A; Amoura Z; Cervera R; Khamastha MA; Schneider M; Richter J; Guillemin F; Kobelt G; Maurel F; Garofano A; Perna A; Murray M; Schmitt C; Boucot I
Ann Rheum Dis; 2014 Jan; 73(1):154-60. PubMed ID: 23264339
[TBL] [Abstract][Full Text] [Related]
20. [Cost of systemic lupus erythematosus for adult patients with active and treated disease in France (LUCIE study)].
Amoura Z; Deligny C; Pennaforte JL; Hamidou M; Blanco P; Hachulla E; Pourrat J; Queyrel V; Garofano A; Maurel F; Levy-Bachelot L; Boucot I
Rev Med Interne; 2014 Nov; 35(11):700-8. PubMed ID: 24630588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
